Investor Relations Home
|IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.|
The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts. We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues. It is possible that the information we post on social media channels could be deemed to be material information. We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page (www.facebook.com/IRIDEX) and Twitter feed (https://twitter.com/IRIDEX).
|02/27/14||IRIDEX Reports 2013 Fourth Quarter Results|
|Record Revenue of $10.6 Million in Quarter
MOUNTAIN VIEW, Calif., Feb. 27, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter ended December 28, 2013.
Revenues were $10.6 million in the fourth quarter of 2013, up 15% from $9.2 million in the prior year comparable period and up sequentially from $9.5 million in the third quarter of 2013.
Gross margin for the fourth quarter of 2013 was 48.6%, up from 47.0% in the prio... |
|02/20/14||IRIDEX Announces Fourth Quarter and Full Year 2013 Conference Call and Release Date|
|MOUNTAIN VIEW, Calif., Feb. 20, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its fourth quarter and full year 2013 financial results after the market closes on Thursday, February 27, 2014. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, February 27, 2014 to discuss the results of the quarter and full year and other business developments.
|01/28/14||IRIDEX Announces Preliminary Unaudited Revenues For 2013 Fourth Quarter and Year End|
|MOUNTAIN VIEW, Calif., Jan. 28, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today reported preliminary revenues of approximately $10.6 million and $38.3 million for the fourth quarter and full year 2013, respectively. Preliminary revenues in the fourth quarter exceeded the high end of the Company's guidance and were driven by a continued strong uptick in sales of laser systems both in the U.S. and internationally. Management had projected revenues to be between $10.2 million and $10.5 ... |
|11/13/13||IRIDEX To Introduce Four New Products At Annual AAO Meeting|
|Fifteen physicians, seven new to the IRIDEX podium, will discuss their experiences using MicroPulse™ for retinal and glaucoma therapies
MOUNTAIN VIEW, Calif., Nov. 13, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that it would introduce four new products at the annual meeting of the American Academy of Ophthalmology to be held November 16-19 at the Ernest N. Morial Convention Center in New Orleans. There will also be several presentations featuring IRIDEX products an... |
|Primary IR Contact|
Chief Financial Officer and Chief Operating Officer
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.